Bone Density Loss: Tenofovir has long been connected to a decrease in bone mineral density, escalating the chance of bone challenges or fractures.HIV-1 infected topics on dolutegravir monotherapy demonstrated immediate and dose-dependent reduction of antiviral action with declines of HIV-1 RNA copies for every ml. The antiviral reaction was taken c